Grade 3 or 4 bleeding
| Age/sex . | Bleeding complication . | Platelet count, ×109/L . | Concomitant antiplatelet agents . |
|---|---|---|---|
| 45/F | Heavy PV bleeding; concomitant fibroids | 33 | No |
| 75/F* | PR bleed | 13 | No |
| 77/F* | Subdural hemorrhage | 81 | No |
| 59/F | GI blood loss | 13 | No |
| 44/F | Gastric antral vascular ectasia | 263 | No |
| 51/M | GI bleeding | 409 | Aspirin |
| 77/F | Fatal intracerebral hemorrhage | 157 | No |
| Age/sex . | Bleeding complication . | Platelet count, ×109/L . | Concomitant antiplatelet agents . |
|---|---|---|---|
| 45/F | Heavy PV bleeding; concomitant fibroids | 33 | No |
| 75/F* | PR bleed | 13 | No |
| 77/F* | Subdural hemorrhage | 81 | No |
| 59/F | GI blood loss | 13 | No |
| 44/F | Gastric antral vascular ectasia | 263 | No |
| 51/M | GI bleeding | 409 | Aspirin |
| 77/F | Fatal intracerebral hemorrhage | 157 | No |
F, female; GI, gastrointestinal; M, male; PR, per rectal; PV, per vaginal.
Same patient with 2 severe bleeding events, in 2005 at age 75 and in 2007 at age 77.